Loading provider…
Loading provider…
Internal Medicine Physician in New York, NY
NPI: 1447221353Primary Employer
Memorial Solid Tumor Group
mskcc.org
HQ Phone
Get MD Dana's Phone NumberMobile
Get MD Dana's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2021 - 2027
NY State Medical License
2000 - 2027
CT State Medical License
2023 - 2026

American Board of Internal Medicine
Medical Oncology
Tulane School of Medicine
medicine.tulane.edu
Medical School
Until 1998
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2002 - 2005
NYU Grossman School of Medicine
med.nyu.edu
Residency • Internal Medicine
1998 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 140 | 337 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 82 | 152 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 68 | 131 |
| 4 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 34 | 62 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 30 | 30 |
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Authors: Zsofia Stadler, Ying Liu, Karen Autio, Wassim Abida, Victor Reuter, Andrew Lenis, Samson Fine, Howard Scher, Mark Robson, Michael Morris, Kenneth Offit, Daniel Danila, Behfar Ehdaie, James Eastham, Maria Carlo, Peter Reisz, Karim Touijer, Alicia Latham, Eugene Pietzak, Vincent Laudone
Journal: Eur Urol
Publication Date: 2022-09-15
Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
Authors: Darren Feldman, Mark Dickson, Manish Shah
Journal: Clin Cancer Res
Publication Date: 2009-11-24
Apalutamide for the treatment of prostate cancer
Authors: Howard Scher
Publication Date: 2018-08
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Enzalutamide, DRUG: CC-115
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Aragon Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Everolimus, DRUG: apalutamide
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Millennium Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: MLN0128